Dr. Morgan Lee McLemore, MD

Dr. McLemore practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. McLemore's NPI, 1790703312, was assigned on July 18, 2006. Dr. McLemore holds Georgia license 59290.

Dr. McLemore's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. McLemore's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. McLemore is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. McLemore to 1 more hospital, 2 group practices and clinics, 1 clinical lab and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLemore practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. McLemore's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. McLemore's licenses on file in 2 states: Georgia and Texas.

CMS data shows 68 Medicare services from Dr. McLemore across 2 procedure codes in 2024, all of them office visits, for 87 Medicare patients. Medicare paid $3,908 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Dr. McLemore in 2024. The largest group is under 65, with 32 patients. 61% of them have high blood pressure, and 46% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McLemore's median patient age at 54, with 60% women.

In 2024, Dr. McLemore wrote 1,617 Medicare Part D claims for 207 patients. 88% of them were for generic drugs. CMS names the drug for 1,363 of them, across 30 drugs with 11 or more claims each, at $498,154 in total drug cost. In 2023, CMS named 1,194 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. McLemore for performance year 2024, reported through an alternative payment model (APM). Dr. McLemore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McLemore as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. McLemore from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $155. It also lists 2 research payments totaling $692 in 2022.